125 related articles for article (PubMed ID: 15256127)
1. [The advances of molecular pathology of follicular thyroid carcinoma].
Zhan Y; Cui QC
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):268-70. PubMed ID: 15256127
[No Abstract] [Full Text] [Related]
2. [Advances in poorly differentiated thyroid carcinoma].
Sun J; Yang D; Cui QC
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):850-3. PubMed ID: 22336216
[No Abstract] [Full Text] [Related]
3. [Problems in pathologic diagnosis of thyroid follicular cell carcinoma].
Li Y; Huo Z; Chen J
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):348-52. PubMed ID: 25030874
[No Abstract] [Full Text] [Related]
4. Follicular Thyroid Carcinoma: A Perspective.
Daniels GH
Thyroid; 2018 Oct; 28(10):1229-1242. PubMed ID: 30039751
[No Abstract] [Full Text] [Related]
5. How to define follicular thyroid carcinoma?
Schmid KW; Farid NR
Virchows Arch; 2006 Apr; 448(4):385-93. PubMed ID: 16506015
[TBL] [Abstract][Full Text] [Related]
6. A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
Juhlin CC
Scand J Surg; 2020 Sep; 109(3):187-192. PubMed ID: 31131695
[TBL] [Abstract][Full Text] [Related]
7. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
8. [Pathologic features of recently identified renal cell carcinoma].
Fan X; Rao Q; Zhang LH
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):569-73. PubMed ID: 24246930
[No Abstract] [Full Text] [Related]
9. Unique follicular carcinoma of the thyroid gland with extracellular deposition of amorphous globular structures mimicking an adenoid cystic pattern.
Yamazaki K
Virchows Arch; 2003 Nov; 443(5):690-2. PubMed ID: 12905018
[No Abstract] [Full Text] [Related]
10. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.
Cracolici V; Ritterhouse LL; Segal JP; Puranik R; Wanjari P; Kadri S; Parilla M; Cipriani NA
Am J Surg Pathol; 2020 Jul; 44(7):881-892. PubMed ID: 32282345
[TBL] [Abstract][Full Text] [Related]
11. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
12. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
13. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.
Proietti A; Giannini R; Ugolini C; Miccoli M; Fontanini G; Di Coscio G; Romani R; Berti P; Miccoli P; Basolo F
Thyroid; 2010 Nov; 20(11):1263-70. PubMed ID: 20950194
[TBL] [Abstract][Full Text] [Related]
14. [Bronchial metastasis of thyroid follicular carcinoma: report of a case].
Hu Y; Sun L; Ding L; Guan J; Lin D
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):336-7. PubMed ID: 25030869
[No Abstract] [Full Text] [Related]
15. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
Hysek M; Paulsson JO; Wang N; Jatta K; Lindh C; Fuentes-Martinez N; Shabo I; Zedenius J; Juhlin CC
Virchows Arch; 2018 Nov; 473(5):639-643. PubMed ID: 29860621
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
Radkay LA; Chiosea SI; Seethala RR; Hodak SP; LeBeau SO; Yip L; McCoy KL; Carty SE; Schoedel KE; Nikiforova MN; Nikiforov YE; Ohori NP
Cancer Cytopathol; 2014 Dec; 122(12):873-82. PubMed ID: 25132659
[TBL] [Abstract][Full Text] [Related]
17. Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.
Gianoukakis AG; Giannelli SM; Salameh WA; McPhaul LW
Mol Cell Endocrinol; 2011 Jan; 332(1-2):9-20. PubMed ID: 21094678
[TBL] [Abstract][Full Text] [Related]
18. [Recently identified renal cell carcinoma].
Zhao M; Teng XD; Sun K; Cheng L
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):478-82. PubMed ID: 24246873
[No Abstract] [Full Text] [Related]
19. TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression.
Paulsson JO; Zedenius J; Juhlin CC
Endocr Pathol; 2021 Dec; 32(4):513-516. PubMed ID: 34676499
[No Abstract] [Full Text] [Related]
20. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
Takano T
Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
